Keyphrases
Acute Hepatitis C
100%
Cost-effectiveness Analysis
100%
Quality-adjusted Life Years
71%
Hepatitis C Virus
57%
Chronic Phase
42%
Cost Savings
28%
Age of Infection
28%
Chronic Hepatitis C Virus Infection
28%
United States
14%
Clinical Outcomes
14%
Clinical Benefit
14%
Economic Benefits
14%
Immediate Treatment
14%
Treatment Duration
14%
Clinical Course
14%
Incremental Cost-effectiveness Ratio
14%
Patients at Risk
14%
Life Cost
14%
Microsimulation Model
14%
Direct-acting Antivirals
14%
Willingness-to-pay Threshold
14%
Hepatitis C Virus Therapy
14%
Hepatology
14%
Nursing and Health Professions
Cost Effectiveness Analysis
100%
Hepatitis C
88%
Quality Adjusted Life Year
55%
Cost Control
22%
Infection
22%
Practice Guideline
11%
Treatment Duration
11%
Clinical Outcome
11%
Disease Course
11%
Incremental Cost-Effectiveness Ratio
11%
Standard of Practice
11%
Virotherapy
11%
Antivirus Agent
11%
Pharmacology, Toxicology and Pharmaceutical Science